## Abstract We show that flavonoids positively regulate type‐II estrogen‐binding site (type‐ll EBS) levels both in MCF‐7 (ER‐positive) and in MDA‐MB231 (ER‐negative) breast‐cancer cells. Type‐ll EBS were measured by a whole‐cell assay at 4°C for 2.5 hr using [^3^H]‐estradiol as tracer. In both cell
Human breast cancer: Heterogeneity of estrogen binding sites
✍ Scribed by H. Skovgaard Poulsen; J. Jensen; C. Hermansen
- Publisher
- John Wiley and Sons
- Year
- 1981
- Tongue
- English
- Weight
- 221 KB
- Volume
- 48
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract Estrogen binding sites were identified on plasma membranes from biopsy materials (N=16) of normal human larynx; such binding was found to be specific. In tissue from 22 cases of laryngeal papilloma, membrane binding of 17‐beta‐estradiol was also specific. Although such binding occurred
## Abstract Sex steroid binding capacity was investigated in malignant cells from 32 patients with acute non‐lymphoblastic leukemia (25 patients with acute myeloid leukemia, 4 with subacute leukemia, 3 with chronic myeloid leukemia in blast crisis) and 30 patients with acute lymphoblastic leukemia.
## Abstract An immunohistochemical method involving the application of purified human prolactin and a specific antiserum to human prolactin, followed by the peroxidaseanti‐peroxidase immunoperoxidase technique, has been used to detect prolactin binding in benign and malignant human breast tissue. T